Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children
Clinical trial NCT00192270 · COMPLETED
Trial details
- NCT number
- NCT00192270
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-10-01
- Primary completion
- 2001-01-01
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.